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ABSTRACT 
 
Alpha-Synuclein (AS) is the protein playing the major role in Parkinson’s disease (PD), a 
neurological disorder characterized by the degeneration of dopaminergic neurons and the 
accumulation of AS into amyloid plaques. The aggregation of AS into intermediate aggregates, 
called oligomers, and their pathological relation with biological membranes are considered key 
steps in the development and progression of the disease. 
Here we propose a multi-technique approach to study the effects of AS in its monomeric and 
oligomeric forms on artificial lipid membranes containing GM1 ganglioside. GM1 is a component 
of functional membrane micro-domains, called lipid rafts, and has been demonstrated to bind AS in 
neurons. With the aim to understand the relation between gangliosides and AS, here we exploit the 
complementarity of microscopy (Atomic Force Microscopy) and neutron scattering (Small Angle 
Neutron Scattering and Neutron Reflectometry) techniques to analyze the structural changes of two 
different membranes (Phosphatidylcholine and Phosphatidylcholine/GM1) upon binding with AS. 
We observe the monomer- and oligomer-interactions are both limited to the external membrane 
leaflet and that the presence of ganglioside leads to a stronger interaction of the membranes and AS 
in its monomeric and oligomeric forms with a stronger aggressiveness in the latter. These results 
support the hypothesis of the critical role of lipid rafts not only in the biofunctioning of the protein, 
but even in the development and the progression of the Parkinson’s disease. 
INTRODUCTION 
 
Alpha synuclein (AS) is an intrinsically disordered 140-amino acid protein highly expressed in the 
cytosol of neurons and primary involved in Parkinson’s disease (PD) [1]. PD is a neuro-
synucleinopathy characterized by the accumulation of AS in fibrillar amyloid plaques in 
dopaminergic neurons of substantia nigra pars compacta (SNPC) [2].  
Physiologically AS plays a crucial role in the homeostasis of synaptic vesicles interacting with 
proteins, such as SNARE family, which are the building blocks of the protein complex involved in 
neuronal exocytosis [3–5].  
In its native state, AS is a monomer which binds to and assemble in alpha-helix conformation on 
lipid membranes [6-7]. Several studies performed on model membranes have demonstrated 
preferential binding of AS to negatively-charged phospholipids such as phosphatidylinositol (PI), 
phosphatidylglycerol (PG) and phosphatidylserine (PS) [8–12]. 
AS has been proposed to localize in vivo on specific plasma membrane domains, called lipid rafts, 
and this co-localization seems essential for the activity of the protein [13]. Lipid raft nano-domains 
have specific lipid composition, being enriched in sphingolipid and cholesterol, and have been 
implicated in several cell molecular pathways, some of which related to cancer, and other 
neurodegenerative diseases [14–16]. The situation is anyway controversial and binding of AS to 
lipid rafts is still under debate. It is still not clear whether AS prefers liquid ordered environment of 
lipid rafts, if the binding is mediated by its components (e.g. GM1 or GPI-anchored proteins) or this 
interaction is involved in the development of the pathology. 
In pathological conditions, AS undergoes a misfolding structural rearrangement promoting the 
formation of toxic fibrillary aggregates in both intracellular and extracellular space in the brain [17–
19]. The misfolding and abnormal aggregation of AS is considered a key event in the development 
of PD. In the last decade studies have been increasingly focused on the intermediate products of AS 
aggregation, called oligomers. The oligomers, rather than amyloid fibrils are considered the major 
toxic species [20–22]. Many environmental and physicochemical factors, such as pH, membrane-
interaction, metal ions and anionic molecules can promote the formation of oligomers [23–25].  
Among the different harmful effects on cell viability, oligomers have shown to induce neurotoxicity 
by cell membrane destabilization, via lipid extraction and pore formation [26–28], leading to 
alteration of calcium flux, membrane conductance and synaptic transmission [19], [29]. Therefore, 
the biological membrane plays a pivotal dual role: on the one hand as a physiological site of action 
of AS and on the other hand as a crucial target of the AS aggregates.  
Some experimental evidences have highlighted the role of (sialic acid-containing 
glycosphingolipids, GMs) in the binding of AS to lipid membranes. GMs are abundant in the lipid 
rafts of the nervous system [30]. Localization of AS with gangliosides, in particular with GM1 
ganglioside, was found in a study using circular dichroism (CD) spectroscopy and molecular 
simulations [13]. The interaction of AS with GM1-containing artificial vesicles has shown to 
promote AS oligomers but prevent fibril formation [31]. Moreover, a neuroprotective role of GMs 
has been proposed [32]. Mice models deficient in GM1 have displayed a stronger accumulation of 
AS in nigral neurons [33, 34], and a consequent potential relevance in the progression of PD. 
In this complex framework, we undertake a study on the interaction of AS with model membranes 
endowed with GM1 molecules (components of lipid rafts) in different aggregation states, i.e. 
monomers (physiological state) and oligomers (pathological form). We exploit the potentiality of 
atomic force microscopy (AFM) to obtain morphological information about molecular interactions 
at near-physiological conditions. We combine AFM measurements to small angle neutron scattering 
(SANS) and neutron reflectometry (NR) taking advantage of the sensitivity of neutrons to isotopes 
to obtain detailed structural information about the effects induced by AS on different model 
membrane systems [35], [36]. We demonstrate that GM1 gangliosides enhance binding of AS 
monomers to the lipid membrane suggesting an important role of GMs in the binding of AS to lipid 
rafts. Moreover, we show that in the presence of oligomers GM1 affects the type of membrane-
interaction of the AS aggregates with the bilayer, indicating an active role of these molecules in the 
onset of PD.  
 
MATERIALS AND METHODS 
 
Biological molecules and chemicals  
18:1 (Δ9-Cis) PC (1,2-dioleoyl-sn-glycero-3-phosphocholine, DOPC), 14:0 PC d54 (1,2-
dimyristoyl-d54-sn-glycero-3-phosphocholine, d54DMPC), 16:0 PC d62 (1,2-dipalmitoyl-d62-sn-
glycero-3-phosphocholine, d62DPPC) and ganglioside GM1 (Brain, Ovine-Sodium Salt) have been 
purchased from Avanti polar Lipids (Alabaster, USA). Expression and purification of human wild-
type Alpha synuclein (AS) was performed by the group of Prof. Giuseppe Legname (Laboratory of 
Prion Biology, SISSA - Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy) Briefly, 
the expression of the protein was performed into E. coli strain BL21 (DE3) transformed with a 
vector pET11a carrying the nucleotide sequence of human wild-type AS. Cells were grown in 100 
mg/mL ampicillin containing Luria-Bertani broth at 37 °C until an A600 of about 0.6, followed by 
induction with 0.6 mM isopropyl β-thiogalactopyranoside for 5 hours. The protein was successively 
extracted by the bacterial periplasm via osmotic-shock and purified by anion-exchange 
chromatography according to the method of Huang and colleagues [37]. Deuterium oxide (Heavy 
water, Water-d2, D2O) has been purchased from Sigma Aldrich. FeCl2 solution was prepared by 
dissolving salt powder (Sigma Aldrich) in ultrapure 18.2 MΩ·cm H2O (Milli-Q, Millipore SpA, 
Milan, Italy) and filtered with a sterile syringe-filter (0.22 μm) prior to use.  
 
AS aggregation 
AS aggregation was performed by mixing 100 µg of protein (final concentration: 35 µM) with 2 
mM FeCl2. Protein solution was incubated at 37 °C under shaking for 1 hour. The products of 
aggregation were analyzed by AFM imaging. The aggregation induced by iron was also monitored 
by the Tioflavin T (ThT) assay. A total of 10 µM ThT was added to each sample in a final working 
volume of 200 µL per well. Fibril formation was monitored on either a GEMINI EM plate reader or 
a Spectramax M5 (Molecular Devices). Each condition (AS and AS + FeCl2) was run in triplicate, 
in 96 black well plates; each well containing 1 teflon bead. The plate was incubated at 37°C, 
shaken, and ThT fluorescence readings were recorded every 5 min for 72 hours. For each assay run, 
the background fluorescence was also recorded.  
 
Lipid vesicle preparation for model membranes fabrication  
Lipid molecules were dissolved in the appropriate organic solvent (Chloroform for phospholipids 
and chloroform/methanol 2:1 for GM1) and combined in the appropriate ratios. Lipid solutions 
were deposited on round bottom boiling flasks and the organic solvent was let to evaporate under a 
gentle stream of nitrogen. Samples were placed under vacuum overnight in order to completely 
remove solvent residues and re-suspended in 150 mM NaCl D2O buffer. Freeze-thawing method 
was applied to obtain multilamellar vesicles (MLVs) [38]: briefly, samples were treated with 
repetitive cycles (n=5) of freezing in nitrogen solution and thawing in warm water. Then, MLVs 
were extruded 51 times through a polycarbonate membrane with 100 nm sized pores using a 
commercial extruder (Avanti Polar Lipids), to form small unilamellar vesicles (SUVs).  
 
Atomic force microscopy (AFM) 
AFM imaging was carried out on a commercial MFP-3D Stand Alone AFM microscope (from 
Asylum Research, Santa Barbara, CA) working at room temperature in dynamic AC-mode. 
Commercial silicon cantilevers (BL-AC40TS-C2, Olympus Micro Cantilevers, nominal spring k 
0.09 nN/nm and OMCL-RC800PSA-1, Olympus Micro Cantilevers, nominal spring k 0.76 nN/nm) 
have been chosen for imaging in liquid and air conditions, respectively. Images (of 2 μm  2 μm or 
5 μm  5 μm size) were acquired in a 512  512 pixel block (with lateral resolution of 3.9 and 9.7 
nm, respectively) at a scan speed of 0.6-1.0 lines/s. 
For AFM analysis of AS molecules, 10 µL of each protein species solution at 0.35 µM were spread 
onto 0.6  0.6 cm2 piece of freshly cleaved mica, left to incubate for 1 min, gently rinsed 3 times 
with Milli-Q H20, dried with a stream of nitrogen and imaged by AFM. 
For AS membrane-interaction investigation we prepared two different model membranes: one made 
by DOPC phospholipid and one made by DOPC+GM1 ganglioside in a molar ratio of 10:0.5. 
100 µL of SUVs solution (0.5 mg/mL in 2 mM CaCl2) of specific lipid composition were spotted on 
freshly cleaved mica attached to the AFM liquid chamber by ultrafast glue. The sample was left to 
incubate for 15 minutes at room temperature to promote vesicle adsorption, fusion and the 
formation of lipid bilayer on the surface. Then the lipid membrane was gently rinsed three times 
with Milli-Q H20 before AFM analysis to remove the excess of vesicles from the liquid sub-phase. 
We used two different amounts of protein, 10 µg and 100 µg (final AS protein concentration of 450 
nM and 4.5 µM in the AFM liquid chamber, respectively) corresponding to a protein/lipid ratio 
(P/L) of 2:1 and 20:1. The protein was incubated to the planar lipid bilayer for 10 minutes and then 
imaged by AFM. AFM image analyses were performed using Gwyddion, an open-source modular 
program for scanning probe microscopy data visualization and analysis [39]. Data regarding size 
distribution of the AS molecules, the GM1-nanodomains and the AS aggregates on DOPC+GM1 
bilayer were obtained using the grain analysis macro of the Gwyddion software. Graphs 
representing AFM trace profiles and height distributions were obtained using the Igor Pro software 
(Wavemetrics, US).   
 
Small angle neutron scattering (SANS) and neutron reflectometry (NR)  
While DMPC has been used as phospholipid matrix for the shorter SANS experiments, we used 
DPPC for NR, to ensure membrane stability during the long-lasting NR experiments. The use of 
deuterated phospholipids helps enhancing the visibility of the protein in interaction with the lipid 
bilayers, thanks to the induced membrane contrast change (cf. Table S1 of the supporting 
information), the scattering length density of the lipids being around 7×10-6Å-2, while that of 
proteins is around 2.5×10-6Å-2.  
The unpolarized beam NR measurements were carried out at the GINA neutron reflectometer at the 
Budapest Neutron Centre (BNC) [40], [41]. The membrane was measured at a neutron wavelength 
of 4.63Å in an aluminium liquid cell (temperature controlled by water circulation to 0.1°C) which 
held a 707010 mm3 Si (100) block with an extremely smooth surface (rms roughness of 0.3 nm) 
for membrane formation. The neutron beam entered the Si block through the 7010 mm face and 
was incident on the membrane from the Si block side. 
The single supported d62DPPC membrane investigated by NR was diluted to the concentration of 
0.5 mg/mL and deposited by vesicle fusion. Prior to the NR experiment, the Si block of the cell was 
cleaned by organic solvents, then washed with Milli-Q H2O and finally it was functionalized in a 
plasma cleaner for 15 minutes.  
The SANS experiments were performed on the SANS-YS instrument at the Budapest Neutron 
Centre at two wavelengths and two sample-to-detector distances to cover a wide q-range, from 
0.005 to 0.4 Å
-1
. Vesicles at a concentration of 40 mg/mL were used for the SANS measurements 
and two model membrane systems (d54DMPC; and d54DMPC + GM1 were investigated in a 10:1 
molar ratio) a) alone (as prepared), b) in the presence of Fe(II) ions and c) in interaction with the 
protein at different states of aggregation (monomers and oligomers) to the final protein/lipid molar 
ratio 2:1. Samples, placed in quartz cells (produced by Hellma) were measured at 37°C, above the 
melting temperature of the lipid chains.  
 
RESULTS AND DISCUSSION 
 
AFM measurements of Alpha synuclein molecules 
Prior to investigate the membrane-interaction of human wild-type AS) in different aggregation 
states, monomeric vs oligomeric, we performed a morphological analysis of both protein molecules 
via atomic force microscopy. As detailed in the Materials and Methods section, AS was spread onto 
freshly cleaved mica and analyzed in dry condition in dynamic mode. Imaging of monomeric AS 
showed the presence of globular spots with a height distribution in the range of  0.3-0.8 nm (Fig. 1 
A), confirming the presence of both monomers and dimers, in agreement with previous experiments 
via scanning probe microscopy [42]. A comparative analysis was made with AS after treatment 
with Fe(II) ions.  
We focused on the iron-mediated aggregation of AS because both in vivo and in vitro evidences of 
strong correlation between iron accumulation and AS aggregation have been reported in PD [43–
45]. Our approach was to investigate the aggregation of AS in pathological conditions, at high 
levels of iron, and compare the membrane-binding of the protein in different artificial model 
membranes. AS was first incubated in vitro with a high concentration iron salt solution for 1 h at 37 
°C under shaking condition. AFM imaging revealed a fast aggregation induced by iron, with the 
formation of globular protein aggregates, which resemble oligomers (Fig. 1 B). These protein 
particles exhibit vertical dimensions in the range of 2.0-6.0 nm in agreement with a dimensional 
range of previous characterization of AS oligomeric species [43–45]. Prolonged incubation of the 
protein with iron did not promote fibrillar aggregates, suggesting that they could belong to an 
aggregation process different from fibril formation (cf. ThT assay reported in the Supporting 
Information).  
 
 
Figure 1. AFM imaging of human wild-type AS molecules. (A) AFM morphology of AS monomers and 
(B) AS oligomers with the relative section analysis profiles and distribution of heights. Proteins were 
spotted on freshly cleaved mica and analyzed in dynamic mode in dry conditions. Scale bar: 200 nm. 
Height distribution of monomers and oligomers were calculated from n = 5 images.  
 
Effect of GM1 on the interaction of AS with supported lipid bilayers 
 
AFM measurements 
To assess the effect of GM1 on AS-membrane binding, we produced two planar model lipid 
systems: a one-component phospholipid membrane made by DOPC and a two-component lipid 
bilayer containing DOPC and GM1 molecules at a molar ratio of 10:0.5. These systems were then 
analyzed via AFM dynamic imaging in liquid environment.  
AFM topographic analysis of membranes of DOPC alone showed a very flat and clean lipid surface 
with the presence of rare lipid defects represented by dark regions (Fig. 2 A). These defects have a 
depth of 2.0 nm which matches with the thickness of the upper monolayer of the membrane 
indicating that the defect is associated with the upper monolayer instead of the entire lipid bilayer. 
The analysis of different areas (n > 10) of the membrane showed less than 5% of lipid defects 
proving the good quality of the bilayer.  
Similar to the DOPC bilayer, the membrane made by DOPC + GM1 exhibited high quality in terms 
of cleanliness and lipid coverage (> 90%). In addition, it displayed the presence of bright spots on 
the surface, which can be assigned to GM1 molecules assembling into nano-domains (Fig. 2 B). 
Most of these nano-islands have a height in the range 0.5–1.5 nm (Fig. 2 C). The bilayer displays 
rare defective areas which appear deeper than a monolayer, with a depth range corresponding to that 
of a complete lipid bilayer (around 4.0 nm). Extensive AFM and X-ray diffraction studies [49], [50] 
were reported on the propensity of GM1 gangliosides to partition into domains on model 
membranes formed by different PC phospholipids species. The height range of these domains were 
shown to range from 1.0 to 2.0 nm, in line with our AFM data. Moreover, we found a few larger 
GM1-nanodomains of 2.0 to 3.0 nm size (Fig. 2 C). These values could be due to an electrostatic 
repulsion occurring between the negatively-charged silicon nitride AFM tip and the polar GM1 
headgroups, an effect which may depend on the applied force and the AFM imaging conditions 
[51].  
 
Figure 2. AFM topography of model membrane systems. (A) DOPC and (B) DOPC + GM1 (10:0.5 
molar ratio) membranes with respective trace profiles along the surface. Blue inverted triangles 
indicate the nano-domains formed by GM1 molecules in the bilayer. Images were taken in liquid 
solution in dynamic mode. Scale bar: 1.0 µm. (C) Height distribution of GM1-domains calculated 
taken from multiple images (n=5). 
 We proceeded then to investigate the two model membrane systems, with and without GM1, in 
interaction with AS monomers / oligomers. We analyzed the binding of AS to the bilayer using two 
different protein concentrations (450 nM and 4.5 µM), corresponding to a protein/lipid ratio (P/L) 
of 2:1 and 20:1 respectively. AS-phenotypic effects on membrane have in fact been shown to 
dramatically depend on the protein concentration and the P/L ratio [49–51]. The chosen 
concentrations are very close to physiological conditions, the AS being present in neurons in the 
low-micromolar concentration range [55].  
We incubated AS with the model membranes and monitored the interaction via AFM. The 
monomeric form of AS at a P/L ratio of 2:1 showed a poor interaction with the DOPC bilayer 
leading to the formation of defect sites with a depth range of about 1.0-1.5 nm (Fig. 3 A). This can 
be associated with the AS intercalation in the upper leaflet of the bilayer (one lipid layer is around 
2.5 nm thick). The increase of the P/L ratio to 20:1 leads to the formation of larger islands 
characterized by heights of about 2.0 nm (Fig. 3 B). Since the thickness of fully-hydrated DOPC 
bilayer is around 5.0 nm [56], we assumed that monomeric AS is able to remodel the bilayer 
morphology intercalating in the upper lipid monolayer and leading to a thinning and lateral 
expansion of the lipid molecules. This mechanism has been speculated in other experimental studies 
on the interaction of AS monomer, as well as of antimicrobial peptides [54–56], with both planar 
and vesicular model lipid membranes of different lipid composition [57–60]. Moreover, membrane 
thinning processes have been associated with biological processes mediated by AS, such as in vivo 
synaptic vesicle formation [4] and, in general, endocytosis [64], [65].  
The incubation of AS monomers to DOPC bilayer containing GM1 molecules showed surprising 
results. At low AS concentration (P/L 2:1) we observed a stronger interaction of the protein with the 
bilayer, when compared to the membrane lacking GM1; in fact we can observe (Fig. 3 C) the 
formation of larger defect sites then those observed in Figure 3 A-B. Cross sectional analysis of 
these patches reveals defects with a depth of 0.5 nm and white structures with heights in the range 
of 0.4-1.0 nm. Since the height of AS monomer has been calculated to be around 0.5-1.0 nm in 
AFM liquid measurements according to its adopted globular or extended conformation [66], our 
results supports a scenario in which the protein first “sit” on the bilayer via GM1-interaction and 
then slowly penetrate in the upper layer of the membrane. 
Further, isolated nano-protrusions previously attributed to GM1 (Fig. 2B) disappear upon protein 
addition, suggesting that AS-membrane interaction is driven and enhanced by the GM1 molecules.  
This hypothesis is confirmed by increasing P/L to 20:1; the bilayer was almost completely 
defective, characterized by AS intercalation, with deeper, large islands of about 2.0 nm height. Only 
few areas of the membrane were unaffected by AS interaction (Fig. 3 D). All in all, we observed a 
10-fold increase of AS monomeric interaction with the bilayer in the presence of GM1 molecules 
compared to the DOPC bilayer. These results evidence an active role of GM1 in mediating and 
strongly enhancing the interaction of AS with lipid membrane. We proved for the first time a direct 
and GM1-mediated increased binding of AS to an artificial lipid system. GM1 being a marker for 
lipid rafts in the cell membrane, the result is in agreement with the results of a previous study which 
reported a co-localization of monomeric AS with lipid raft components in brain extracts [13]. 
 
 
Figure 3. AFM measurements of monomeric AS interaction with DOPC and DOPC + GM1 model 
membranes. Evaluation of AS monomer binding and interaction with DOPC lipid bilayer at (A) 
P/L=2:1 and (B) P/L=20:1 protein/lipid ratio (P/L), respectively. (C-D) Equal experiments were 
performed for DOPC + GM1 membrane (10:0.5 molar ratio). Line profiles for each sample are shown 
under AFM images. In the line profile panels the height of the membrane was set to 0, in order to 
emphasize the height variations due to the interacting proteins. Images were taken in liquid solution in 
dynamic mode. Scale bar: 1.0 µm.  
 
The interaction of AS oligomers with model membranes DOPC and DOPC + GM1 were tested. The 
addition of protein aggregates at P/L ratio 2:1 to the DOPC bilayer led to the formation of 
oligomeric clusters (Fig. 4 A) with a similar shape and lateral dimensions (0.2-1.0 µm) of fractal-
like structures formed by the monomeric species at P/L 20:1 (Fig. 3 B), the main difference being in 
the much larger height, of about 5.0-10.0 nm. We can speculate of a similar membrane-interaction 
effect between monomers and oligomers with the difference that the aggregates species display a 
more aggressive behavior detectable already at low P/L ratio. Several mechanisms of interaction 
have been proposed for different oligomeric species involved in PD, such as pore formation and 
disruption of the bilayer [28], [63–65]. However, in our case the binding of oligomers does not 
seem to induce any of the mentioned effects, but seems to exhibit an interaction and/or protein 
accumulation in the upper monolayer of the membrane. When we increased P/L ratio to 20:1, 
surprisingly, we did not observe a significant increase in the lipid area covered by the clusters 
(except for a slight increase from 13% to 18%). Moreover, we did not observe  any other effect 
affecting the structural integrity of the membrane. On the contrary, the presence of GM1 drastically 
changed the interaction of oligomers with the lipid bilayer, now almost completely covered by 
protein particles (Fig. 4 B). The analysis of the heights showed a distribution very similar to the 
oligomers spotted on bare mica as shown in figure 1 B (Fig. 4 C). Also in this case GM1 seems to 
have played a major role in modulating the interaction of the AS oligomers with the bilayer. These 
results suggest that GM1 is able to prevent the formation of AS aggregated clusters on the lipid 
bilayer but seems to increase the membrane coverage of oligomers to the membrane, as in presence 
of a specific interaction with the ganglioside. This result could mean opposite effects in terms of 
toxicity in the pathology.  
Currently, there is a general consensus on a neuroprotective function of GM1 in PD. GM1 has been 
shown to block the in vitro fibrillar aggregation of AS [31]. Moreover, a PD-mice model has 
displayed reduced levels of AS-aggregation and protection against loss of dopaminergic neurons 
after GM1-administering [32]. GM1 and the lipid rafts are also involved in other neurodegenerative 
disorders (Alzheimer’s disease (AD) and Prion disorder (PD)), but the role seems to be different. 
GM1 gangliosides have been shown to promote enhanced toxic aggregation of the amyloid β 
protein of AD [70]. Moreover, a GM1 interaction with the prion protein on the membrane of cell 
cultures seems to play an active role in the development of PD [71]. Considering these latter facts, a 
functional explanation of membrane-binding of AS in the presence of GM1 ganglioside, especially 
in the case of oligomeric AS, requires additional investigations in living systems (cell cultures, mice 
models).  
 
 
Figure 4. AFM measurements of AS oligomers-interaction with DOPC and DOPC + GM1 model 
membranes. (A) DOPC and (B) DOPC + GM1 bilayers after the addition of AS oligomers at P/L=2:1 
protein/lipid ratio. Images were taken in liquid solution in dynamic mode. Scale bar: 1.0 µm. (C) 
Height distribution of protein particles on DOPC + GM1 bilayer. 
 
SANS measurements 
In order to obtain a better comprehension on the role of GM1 molecules in promoting AS binding to 
model membranes, we complemented AFM analysis with small angle neutron scattering (SANS) 
experiments on small unilamellar lipid vesicles (size ~ 100 nm) of similar lipid composition to the 
ones used for AFM experiments (DMPC and DMPC + GM1) – in presence of AS monomers and 
oligomers. In this set of experiments, we used deuterated DMPC phospholipid (d54DMPC), which is 
comparable to DOPC molecules, having the same lipid headgroup and being in fluid state at the 
working temperature. To avoid data misinterpretation, the effect of the Fe(II) on the model 
membranes has also been investigated by SANS (cf. SI).  
Figure 5 displays spectra collected on the DMPC + GM1 systems at T=37° C. From the low-q 
region of the spectra from we can gain information on the entire aggregates, i.e. the vesicles size. In 
this q-range no significant difference is visible between before and after the interaction of the 
membrane with the proteins. In the presence of iron a partial destabilization of the membrane was 
observed (cf. SI), but this effect does not occur when AS oligomers are present in the solution, 
indicating that Fe(II) ions are strongly bound to the oligomers and are not released to the solvent 
and to the membranes. A significant effect is observed in the presence of AS oligomers. The SANS 
spectrum evidences the presence of large surface fractals sized more than hundred nm (which is the 
limit of the length scale investigated, that is ~ 120 nm). In fact, the slope of the profile approaching 
the lowest q-range shows a power low decrease with an exponent of −3.2, typical of a surface 
fractal dimensionality [76]. In addition, the spectrum indicates the presence of ~20 nm sized objects 
(evidenced by the broad peak found at q~0.01 nm
-1
), which may correspond to AS oligomers bound 
to the membrane, which otherwise would not be visible, giving a too low contribution to scattering 
because of their low total amount. The formation of large aggregates upon interaction may be 
associated with GM1 ganglioside inducing anchoring of AS oligomers to the membranes and 
promoting the formation of oligomer-based big aggregates extending in the extra membrane space. 
Alternatively, AS oligomers, having anchored to the GM1-containing membranes, act as linkers 
among membranes, promoting vesicles aggregation. The AFM measurements support this latter 
scenario. 
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Figure 5. SANS spectra of the d54DMPC + GM1 membrane investigated alone (as prepared – black) 
and in interaction with the AS protein monomers (orange) or oligomers (blue). Measurements were 
performed at T = 37° C. 
 
A core multi shell model has been fitted to SANS data of Fig. 5. with the SasView program [72], 
modeling the lipid vesicles as spherically shaped objects with a water core and formed by three 
contrasting layers: internal heads, deuterated chains and external heads. Each layer is characterized 
by its thickness and scattering length density (SLD). After having allowed for an interaction of AS 
with the bilayer, we did not observe any significant change in the SLD profile (cf. SI and Fig. 6). 
 
Figure 6. Scattering length density (SLD) profiles of d54DMPC + GM1 membrane in its as prepared 
state (black) and in interaction with the protein monomers (orange) as well as oligomers (blue), 
obtained by fitting a core-multi shell model to the SANS data. 
 
On the one hand, when AS interacts with pure DMPC phospholipid vesicles, no significant 
difference is observed in the low-q region upon the interaction with the protein, and no sensitive 
effect is detected in the presence of a small amount of Fe(II) added (cf. SI). On the other hand, a 
spectral change is observed in the high-q region, which is sensitive to the membrane form factor 
(Fig.7).  
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Figure 7  SANS spectra of d54DMPC phospholipid membrane investigated alone, as prepared (black) 
and in interaction with the protein monomers (orange) and oligomers (blue). Measurements were 
performed at T = 37° C. 
 A core multi shell model has also been fitted to the experimental data in Fig. 7.. The SLD profiles 
obtained for in the as prepared state and upon interaction with AS are shown in Figure 8 (cf. 
Supporting Information for fit parameters). Results are consistent with a modification of the 
external heads layer, the contrast and thickness of which are affected by the presence of AS 
monomers and oligomers. Spectral changes are consistent with a thinning of the apolar and a 
thickening of the external polar region of the membrane, contrast of which is also increased, as if 
both AS monomers and oligomers interacted with the phospholipid membrane surface. 
 
 
 
Figure 8. SLD profiles of the d54DMPC phospholipid membrane as prepared (black) and in interaction 
with the protein monomers (orange) and oligomers (blue), obtained by fitting a core-multi shell model 
to the SANS data.  
 
Neutron reflectometry 
To further study the protein-to-membrane interaction at a molecular scale, neutron reflectometry 
has been applied. NR is a suitable technique to unveil such details on the nanometer scale [35], [73]. 
Plefferkom and co-workers, by a combination of molecular dynamics and neutron reflection, 
validated the hypotesys that the interaction of AS monomers with a lipid membrane is limited to the 
external layer of the membrane [74], but similar investigations on the aggregated species of AS 
have not been performed to date. 
To fill this gap we applied neutron reflectometry to investigate the cross structural changes caused 
by oligomeric AS aggregates to a single phospholipid membrane prepared by deuterated DPPC 
(d62DPPC). After silicon oxyde characterization (reflectivity measurement of the Si block surface 
with no membrane), a DPPC phospholipid membrane was deposited by vesicle fusion on the 
surface of the Si block and the NR was measured. Then the oligomer solution was injected directly 
in the measuring cell to reach the final P/L ratio of 2:1. 
After 1 hour of incubation NR was recorded, revealing that interaction occurred (Figure 9). In the 
following, another AS oligomers solution was injected into the cell, to reach the final P/L ratio of 
4:1, to investigate whether interaction occured again and to what extent or the presence of AS 
species anchors the membrane surface (binds to the target membrane) which affects the interation. 
The final system was characterized in two contrasting solvents: H2O and D2O. Data with the best 
fits and the resulting SLD profiles are reported in Figure 9. Analysis has been performed by the 
software MotoFit [75] accounting for a SLD of 2.5×10
-6
Å
-2
 for the protein, while the structural 
results and the SLD valued used for lipids are reported in Table 1.  
Results indicate that the membrane coverage was good (85%). A water layer of 6 Å thickness was 
found between the membrane and the silicon support. The interlayer membrane roughness was 
found to be around 3 Å. The NR data analysis confirmed the SANS results, unveiling that for AS 
monomers and oligomers alike the interaction with the membrane is limited to the outer layer of the 
lipid bilayer. Moreover, the interaction did not affect membrane coverage, i.e. the membrane 
stability. Data analysis also reveals that the extent of AS oligomers interaction with the 
phopsholipid membrane is slightly affected by the presence of preexistent aggregates. Increasing 
the quantity of incoming oligomers, in fact, we noted an increase of the penetration depth and a 
small increase in membrane’s external layer thickness, compatible with an accumulation of protein 
on the membrane outer layer, in full accordance with AFM results reported in figure 4 A.  
 
 
 
Figure 9. (A) Reflectivity curves and (B) SLD profiles obtained by the d62DPPC membrane in D2O 
before and after the injection of AS oligomers. DPPC bilayer before (blue) and after AS oligomer 
incubation to the final P/L ratio of 2:1 (orange) and of 4:1 (green). Measurements were performed at 
T = 45° C, over the lipid melting temperature. 
 
 Membrane Membrane + AS oligomers Membrane + AS oligomers (x2) 
 T SLD S t SLD p s t SLD p S 
Heads in 9 1.75 25 9 1.75  25 9 1.75  25 
Chains in 14 7.1 15 14 7.1  15 14 7.1  15 
Chains out 13 7.1 15 13 6.9 4% 15 15 6.3 17% 15 
Heads out 9 1.75 25 9 1.8 7% 25 10 1.9 20% 25 
 
Table 1. Structural parameters of the d62DPPC membrane investigated by NR before and after the 
interaction with AS oligomers. Abbreviations: t = layer thickness (± 1Å); SLD = layer SLD (± 0.1×10-
6Å
-2
); p = estimated amount of protein inserted (± 3% volume); s = layer solvent penetration (± 5% 
volume). Normal numbers indicate membrane parameter values before, bold italics numbers indicate 
values after AS-membrane interaction. 
 
CONCLUSIONS 
 
With extended implications to the Parkinson’s disease, a multi-techniques study was performed to 
clarify on the role of gangliosides in the interaction of artificial lipid membranes with alpha 
synuclein (AS) – in its monimeric and oligomeric form. We have shown that monomeric AS is able 
to remodel the membrane structure leading to bilayer thinning in both phospholipid and 
phospholipid containing GM1 membranes. The changes are not related to the type of AS-mediated 
effect on the bilayer but rather to the ability of GM1 molecules to enhance the membrane-binding of 
the AS, which supports speculations on an active role of the gangliosides in the subcellular 
localization of the protein. GM1 molecules enrich the raft domains of neuronal cell membranes, 
which affirm the hypothesis of a critical role of lipid rafts in the biological function of the protein. 
The iron-mediated AS oligomers have been demonstrated to behave similar to the monomers, 
except for their increased tendency in membrane binding. Even in this case, GM1 acts as a 
membrane-binding mediator, while triggering different binding routes of the aggregates with the 
membrane. The biological functionality of these interactions needs to be defined in living model 
systems. 
In conclusion, we found evidences of crucial involvement of gangliosides, consequently of lipid 
rafts in the membrane-binding of AS in physiological as well as in pathological conditions. 
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Figure S1. SANS spectra (dots) and best fits (lines) of the vesicle systems (top line:phospholipid only, 
bottom: phospholipid+GM1) investigated as prepared, in Fe(II) containing solution, and in interaction with 
the protein at different states of aggregation. 
 
 
 
Table 1. Fitting results for the SANS measurements 
 
SLD heads in 
(±0.1*10-6Å-2) 
Thickness 
heads in (±1Å) 
SLD chains 
(±0.1*10-6 Å-2) 
Thickness 
Chains (±1Å) 
SLD heads out 
(±0.1*10-6Å-2) 
Thickness 
Heads out 
(±1Å) 
DMPC 1.7 7 6.3 32 1.7 8.5 
DMPCFe 1.7 7 6.4 32 1.7 8.6 
DMPC+αmon 1.7 7 6.3 31 2 14 
DMPCFe+αoli 1.7 7 6.5 29 2 14 
       
DMPC-GM1 1.65 7 5.6 33 1.75 12 
DMPC-GM1Fe 1.65 7 6 32 1.75 12 
DMPC-GM1+αmon 1.67 7 5.6 32 1.64 13 
DMPC-GM1Fe+αoli 1.65 7 5.6 32 1.75 13 
 
 
  
 
Figure S2. (A) TioflavinT (ThT) assay of wild-type (WT) AS in presence and absence of FeCl2. (B) 
AFM images of each protein aggregates after 72 hours of incubation. In the absence of iron the 
aggregation of the protein reaches saturation after 50 hours, displaying the typical sigmoidal curve for the 
aggregation of amyloid proteins. The AFM image confirms the presence of fibrillar and amorphous 
aggregates. On the contrary, iron does not induce any significant increase in the fluorescent emission due to 
the presence of fibrillar and/or beta-rich oligomeric species of AS. AFM analysis confirms the presence of 
globular aggregates similar to those reported in Figure 1B on page 6,. Scale bar: 1 µm.  
  
